Caricamento...
A312 POST MARKET USE OF TEDUGLUTIDE IN CANADA IN PATIENTS WITH SHORT BOWEL SYNDROME ON HOME PARENTERAL NUTRITION: THE REAL WORLD SETTING
BACKGROUND: Patients with intestinal failure due to short bowel syndrome (SBS) are dependent on parenteral support (PS). Teduglutide, a glucagon-like peptide-2 (GLP-2) agonist, can reduce PS requirement by enhancing absorptive capacity of the remaining intestine. As it was only approved for use in C...
Salvato in:
| Pubblicato in: | J Can Assoc Gastroenterol |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508186/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.312 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|